期刊文献+

siRNA沉默脂肪酸合成酶基因表达对食管癌细胞增殖的影响 被引量:3

Effect of silencing fatty acid synthase gene(FASN)by siRNA interference on proliferation of human esophageal cancer cells
下载PDF
导出
摘要 目的观察小干扰RNA(siRNA)沉默脂肪酸合成酶基因(FASN)表达对食管癌细胞增殖的影响。方法将化学合成的FASN的小干扰siRNA用脂质体Lipofectamine2000转染人食管癌细胞株TE13细胞,采用的反转录-聚合酶链反应(RTPCR)检测FASN mRNA的表达、Western blot方法检测siRNA干扰后FASN蛋白的表达及与细胞增殖相关的蛋白cyclin D1(CCND1)的表达情况、CCK-8检测细胞增殖、Transwell实验检测细胞迁移能力。结果转染了FASN-siRNA的食管癌TE13细胞,RT-PCR及Western blot结果显示FASN在基因及蛋白水平明显下调(P<0.05);与对照组比较,细胞增殖受到抑制,与增殖相关的蛋白CCND1表达下调(P<0.05);FASN干扰后明显抑制了人食管癌细胞株TE13细胞迁移能力(P<0.05)。结论应用FASN-siRNA体外抑制食管癌细胞FASN的表达,从而抑制食管癌细胞增殖,抑制了细胞迁移,靶向FASN可以作为食管癌治疗的一个新的靶点。 Objective To investigate the effect of silencing fatty acid synthase gene (FASN) by siRNA interference on proliferation of human esophageal cancer cells. Methods Chemically syn- thesized siRNA targeting FASN(FASN-siRNA) was transfected into transfected into human esophageal cancer cell line TEl3 ceils by lipofectamine2000. FASN mRNA was measured by reverse transcription Polymerase chain reaction( RT-PCR), and the expression of FASN, cyclin D1 (CCND1) were detec- ted by Western blotting. Proliferation of TEl3 ceils was determined by CCK-8 assay. The activities of motility of TEl3 cells were assessed by celhranswell chamber invasion assay in vitro. Results In the FASN-siRNA group, the FASN mRNA and protein levels were down-regulated remarkably ( P 〈 0.05 ). The abilities of proliferation were inhibited and level of CCND1 was down-regulated (P 〈 0.05 ). The motility of TEl3 cells were inhibited significantly in vitro (P 〈 0.05 ). Conclusion Silencing FASN could regulate proliferation of human esophageal cancer cells. Targeting FASN may be a new therapeu- tic strategy for human esophageal carcinoma.
出处 《实用临床医药杂志》 CAS 2013年第19期7-10,共4页 Journal of Clinical Medicine in Practice
关键词 FASN基因 食管癌 RNA干扰 fatty acid synthase gene (FASN) esophageal cancer RNA interference
  • 相关文献

参考文献11

  • 1Kuhajda F P.Fatty acid synthase and cancer:new aPPlication of an old Pathway[J].Cancer research,2006,66 (12):5977.
  • 2Mansour M,Schwartz D,Judd R,et al.Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer[J].Int J Oncol,2011,38(2):537.
  • 3Santolla M F,Lappano R,De Marco P,et al.G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancerassociated fibroblasts[J].J Biol Chem,2012,287 (52):43234.
  • 4Mansour M,Schwartz D,Judd R,et al.Thiazolidinediones/PPARgamma agonists and fatty acid synthase inhibitors as an experimental combination therapy for Prostate cancer[J].Int J Oncol,2011,38(2):537.
  • 5Notarnicola M,Tutino V,Calvani M,et al.Serum levels of fatty acid synthase in colorectal cancer patients are associated with tumor stage[J].J Gastrointest Cancer,2012,43 (3):508.
  • 6Davidson B,Stavnes H T,Risberg B,et al.Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions[J].Hum Pathol,2012,43(5):684.
  • 7KimK,Kim H Y,Cho H K,etal.The SDF-1alPha/CXCR4 axis induces the exPression of fatty acid synthase via sterol regulatory element-binding Protein-1 activation in cancer cells[J].Carcinogenesis,2010,31 (4):679.
  • 8Ciznadija D,Liu Y,Pyonteck SM,et al.Cyclin D1 and cdk4 mediate development of neurologically estructive oligodendroglioma[J].CancerRes,2011,71(19):6174.
  • 9Casimiro M C,Crosariol M,Loro E,et al.Cyclins and cell cycle control in cancer and disease[J].Genes Cancer,2012,3(11/12):649.
  • 10Tarapore R S,Yang Y,Katz J P.Restoring KLF5 in Esophageal Squamous Cell Cancer Cells Activates the JNK Pathway Leading to Apoptosis and Reduced Cell Survival[J].Neoplasia,2013,15(5):472.

同被引文献30

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部